Phase II Study of Ganitumab, a Fully Human Anti–Type-1 Insulin-Like Growth Factor Receptor Antibody, in Patients With Metastatic Ewing Family Tumors or Desmoplastic Small Round Cell Tumors - Concepedia

Concepedia

Publication | Closed Access

Phase II Study of Ganitumab, a Fully Human Anti–Type-1 Insulin-Like Growth Factor Receptor Antibody, in Patients With Metastatic Ewing Family Tumors or Desmoplastic Small Round Cell Tumors

217

Citations

19

References

2012

Year

William D. Tap, George D. Demetri, Phillip Barnette, Jayesh Desai, Petr Kavan, Richard Tozer, Pasquale Benedetto, Gregory Friberg, Hongjie Deng, Ian McCaffery,

Journal of Clinical Oncology

Abstract

Ganitumab was well tolerated and demonstrated antitumor activity in patients with advanced recurrent EFT or DSRCT.

References

	Year	Citations

Page 1